BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 33714721)

  • 21. A Vicious Circle of Clonal Haematopoiesis of Indeterminate Potential and Cardiovascular Disease.
    Ehlert CA; Hilgendorf I
    Hamostaseologie; 2021 Dec; 41(6):443-446. PubMed ID: 34942657
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Putative Mechanisms Underlying Cardiovascular Disease Associated with Clonal Hematopoiesis of Indeterminate Potential.
    Burns SS; Kapur R
    Stem Cell Reports; 2020 Aug; 15(2):292-306. PubMed ID: 32735822
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interplay between Clonal Hematopoiesis of Indeterminate Potential and Metabolism.
    Lee MKS; Dragoljevic D; Bertuzzo Veiga C; Wang N; Yvan-Charvet L; Murphy AJ
    Trends Endocrinol Metab; 2020 Jul; 31(7):525-535. PubMed ID: 32521236
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clonal hematopoiesis and vascular disease.
    Amancherla K; Wells JA; Bick AG
    Semin Immunopathol; 2022 May; 44(3):303-308. PubMed ID: 35122117
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clonal hematopoiesis and atherosclerotic cardiovascular disease: A primer.
    Zuriaga MA; Fuster JJ
    Clin Investig Arterioscler; 2023; 35(1):35-41. PubMed ID: 34879980
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clonal haematopoiesis in patients with degenerative aortic valve stenosis undergoing transcatheter aortic valve implantation.
    Mas-Peiro S; Hoffmann J; Fichtlscherer S; Dorsheimer L; Rieger MA; Dimmeler S; Vasa-Nicotera M; Zeiher AM
    Eur Heart J; 2020 Feb; 41(8):933-939. PubMed ID: 31504400
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clonal Hematopoiesis of Indeterminate Potential Reshapes Age-Related CVD: JACC Review Topic of the Week.
    Khetarpal SA; Qamar A; Bick AG; Fuster JJ; Kathiresan S; Jaiswal S; Natarajan P
    J Am Coll Cardiol; 2019 Jul; 74(4):578-586. PubMed ID: 31345433
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clonal hematopoiesis and cardiovascular disease in cancer patients and survivors.
    Fuster JJ
    Thromb Res; 2022 May; 213 Suppl 1():S107-S112. PubMed ID: 36210552
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clonal hematopoiesis: Molecular and clinical implications.
    Kusne Y; Xie Z; Patnaik MM
    Leuk Res; 2022 Feb; 113():106787. PubMed ID: 35091334
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exploring the Associations Between Clonal Hematopoiesis of Indeterminate Potential, Myeloid Malignancy, and Atherosclerosis.
    Menendez-Gonzalez JB; Rodrigues NP
    Methods Mol Biol; 2022; 2419():73-88. PubMed ID: 35237959
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Heart and blood: clonal hematopoiesis].
    Dimmeler S; Zeiher A
    Herz; 2024 Mar; 49(2):105-110. PubMed ID: 38424288
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clonal Hematopoiesis of Indeterminate Potential: Current Understanding and Future Directions.
    Singh I; Singh A
    Curr Oncol Rep; 2023 Jun; 25(6):539-547. PubMed ID: 36928826
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Telomere Attrition and Clonal Hematopoiesis of Indeterminate Potential in Cardiovascular Disease.
    Huang YC; Wang CY
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576030
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic Interleukin 6 Signaling Deficiency Attenuates Cardiovascular Risk in Clonal Hematopoiesis.
    Bick AG; Pirruccello JP; Griffin GK; Gupta N; Gabriel S; Saleheen D; Libby P; Kathiresan S; Natarajan P
    Circulation; 2020 Jan; 141(2):124-131. PubMed ID: 31707836
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clonal hematopoiesis and cardiovascular diseases: role of JAK2V617F.
    Misaka T; Kimishima Y; Yokokawa T; Ikeda K; Takeishi Y
    J Cardiol; 2023 Jan; 81(1):3-9. PubMed ID: 35165011
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clonal haematopoiesis, ageing and kidney disease.
    Vlasschaert C; Lanktree MB; Rauh MJ; Kelly TN; Natarajan P
    Nat Rev Nephrol; 2024 Mar; 20(3):161-174. PubMed ID: 37884787
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Murine models of clonal haematopoiesis to assess mechanisms of cardiovascular disease.
    Wang Y; Sano S; Ogawa H; Horitani K; Evans MA; Yura Y; Miura-Yura E; Doviak H; Walsh K
    Cardiovasc Res; 2022 May; 118(6):1413-1432. PubMed ID: 34164655
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Clinical Challenge of Clonal Hematopoiesis, a Newly Recognized Cardiovascular Risk Factor.
    Sidlow R; Lin AE; Gupta D; Bolton KL; Steensma DP; Levine RL; Ebert BL; Libby P
    JAMA Cardiol; 2020 Aug; 5(8):958-961. PubMed ID: 32459358
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clonal hematopoiesis and cardiovascular disease: deciphering interconnections.
    Stein A; Metzeler K; Kubasch AS; Rommel KP; Desch S; Buettner P; Rosolowski M; Cross M; Platzbecker U; Thiele H
    Basic Res Cardiol; 2022 Nov; 117(1):55. PubMed ID: 36355225
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CHIP Happens: Clonal Hematopoiesis of Indeterminate Potential and Its Relationship to Solid Tumors.
    Reed SC; Croessmann S; Park BH
    Clin Cancer Res; 2023 Apr; 29(8):1403-1411. PubMed ID: 36454121
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.